Use of Bioelectrical Impedance Analysis to Explore the Effectiveness of Stellate Ganglion Block in Patients with Post-Stroke Complex Regional Pain Syndrome: A Retrospective Pilot Study

• Published in: Journal of personalized medicine Vol. 14; no. 3; p. 258
• Main Authors: Ryu, Jin-Whan, Hwang, In-Su, Lim, Seung-Kyu
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 28.02.2024; MDPI
• Subjects: Aphasia; Body composition; Body water; Bupivacaine; Care and treatment; Chronic pain; Complex regional pain syndrome; Cooperation; Edema; Ganglion; Medical research; Medicine, Experimental; Patient compliance; Patients; Physiological aspects; Pilot projects; Rehabilitation; Scintigraphy; Stellate ganglion; Stroke; Stroke patients; electric impedance; complex regional pain syndromes; autonomic nerve block; rehabilitation; stroke
• ISSN: 2075-4426; 2075-4426
• DOI: 10.3390/jpm14030258

Post-stroke complex regional pain syndrome (CRPS) poses challenges in pain assessment for survivors. Stellate ganglion block (SGB) is a treatment, but evaluating its effectiveness is difficult for patients with communication limitations. Edema, a prominent symptom, can serve as an evaluation marker. Bioelectrical impedance analysis (BIA), assessing body composition and fluid status, is used independently of patient cooperation. This retrospective, observational pilot study aims to explore BIA's utility as an assessment tool post-SGB, revealing the effects and time courses of a single SGB on the bodily composition of post-stroke CRPS patients. Seven patients received ultrasound-guided SGB with a 5 mL solution containing 4 mL of 0.25% bupivacaine hydrochloride and 40 mg of triamcinolone into the prevertebral muscle space. BIA compared measures between affected and unaffected arms. The affected arm had higher segmental body water (SBW) and extracellular water ratios before SGB ( = 0.028 and = 0.018, respectively). The SBW of the affected side, the SBW ratio, and the 1 and 5 kHz SFBIA ratios improved over time ( = 0.025, 0.008, 0.001, and 0.005, respectively). Rapid improvement occurred around 3 days post-injection, with maximum effects within approximately 1 week, persisting up to 3 weeks. SGB successfully reduced edema in post-stroke CRPS patients, with BIA serving as a useful tool for follow-up, facilitating the development of efficient treatment plans.